“…Various biofluids including plasma, serum, saliva, urine, tears, amniotic fluid, cerebrospinal liquid, bronchoalveolar fluid, and nipple aspirate fluid were analyzed by SELDI-TOF/MS to identify biomarkers for disease diagnosis . A large number of studies have been reported on the applications of SELDI-TOF/MS in protein profiling of biofluid samples for disease, particularly cancers such as breast, prostate, hepatocellular, ovarian, nasopharyngeal, testicular, colon, lung, pancreas, choriocarcinoma, osteoarthritis, remote ischemic preconditioning, and juvenile idiopathic arthritis [284][285][286][287][288][289][290][291][292][293][294]. The results of these studies showed a potential for large-scale disease screening using SELDI-TOF/MS.…”